Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
weight of evidence
Study period:
23 June 1997 to 15 July 1997
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Remarks:
Conducted according to GLP

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1997
Report date:
1997

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.1 (Acute Toxicity (Oral))
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Reference substance name:
123439-82-7
Cas Number:
123439-82-7
IUPAC Name:
123439-82-7
Constituent 2
Reference substance name:
Tetraammine platinum hydrogencarbonate
IUPAC Name:
Tetraammine platinum hydrogencarbonate
Details on test material:
- Name of test material: tetramine platinum hydrogencarbonate
- Substance type: Technical product
- Physical state: Solid (powder)
- Analytical purity: > 99.9%
- Purity test date: 1997-02-19
- Lot/batch No.: 02/95
- Expiration date of the lot/batch: 1999-12-31
- Stability under test conditions: Stable throughout study according to sponsor
- Storage condition of test material: Stored dry at < 30oC in closed container

Test animals

Species:
rat
Strain:
other: HsdCpb: WU
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Harlan-Winkelmann GmbH, D-33176 Borchen
- Age at study initiation: males 7 weeks; females 9 weeks
- Weight at study initiation: males 156-166 g; females 151-173 g
- Fasting period before study: 16 hours
- Housing: 1 animal/Macrolon cage, type II; soft wood granulate bedding
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20.5-21.6
- Humidity (%): 41-73
- Air changes (per hr): No data
- Photoperiod (hrs dark / hrs light): 12 hrs dark / 12 hrs light

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
CMC (carboxymethyl cellulose)
Remarks:
Trade name TylopurR C 1000 P; 0.5% aqueous CMC: trade name Tylose
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 215 mg/ml
- Amount of vehicle (if gavage): 10 ml/kg
- Justification for choice of vehicle: test substance given as a suspension
- Lot/batch no. (if required): E 114 30100

DOSAGE PREPARATION: test substance suspended immediately before dosing using a homogenizer and magnetic stirrer
Doses:
2150 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Continuous observations for 4-6 hr after dosing, then once per day. Weighed at start of study and day 7 and 14 (or after death if this occurred earlier).
- Necropsy of survivors performed: yes
Statistics:
Not applicable, LD50 higher than the dose administered

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 150 mg/kg bw
Mortality:
One male and one female died on days 5 and 6, respectively.
Clinical signs:
other: Surviving animals: Males (n=4): 2 had no symptoms, 2 showed slightly reduced movement, staggered gait and sunken sides (lasting 1-4 days). Females (n=4): 4 had diarrhoea, 2 had staggered gait, 2 had sunken sides, 1 had reduced movement. Deceased animals
Gross pathology:
No gross abnormalities detected.
Other findings:
No other findings reported

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
The acute oral LD50 value of tetraammineplatinum hydrogen carbonate was determined to exceed 2150 mg/kg bw in male and female rats.
Executive summary:

In an acute oral toxicity test, conducted in accordance with OECD Test Guideline 401 (withdrawn in 2002) and to GLP, HsdCpb: WU rats (5/sex) were gavaged with tetraammineplatinum hydrogen carbonate (as a suspension in aqueous carboxymethyl cellulose) at a limit dose of 2150 mg/kg bw and observed for 14 days.

 

Three males showed reduced movement, staggered gait and sunken sides starting 75 minutes after dosing and lasting until day 1 or 4 after dosing. One of these males additionally showed clonic convulsions, diarrhoea, piloerection, stilted gait, red crusted nose and emaciation, and subsequently died (on day 5 after dosing). The other two males showed no signs of toxicity during the observation period.

 

All females exhibited diarrhoea, and some showed staggered and/or stilted gait, reduced movement and sunken sides. These effects were evident from 90 minutes after dosing, and lasted for 6 days or, in one animal, until death (on day 6).

 

The acute oral LD50 value was therefore determined to exceed 2150 mg/kg bw in male and female rats.

 

Based on the results of this study, tetraammineplatinum hydrogen carbonate does not require classification for acute oral toxicity according to EU CLP criteria (EC 1272/2008).